Dermatol. praxi. 2024;18(4):209-212 | DOI: 10.36290/der.2024.042

Suppurating lesion on the scalp

MUDr. Jan Finsterle1, MUDr. Kateřina Gregorová2, prof. MUDr. Spyridon Gkalpakiotis, Ph.D., MBA1
1 Dermatovenerologická klinika 3. LF UK a FNKV, Praha
2 Pediatrická klinika 2. LF UK a FN Motol, Praha

Tinea capitis is a dermatophytic infection affecting the scalp, most commonly in children. This infection is caused by anthropophilic or zoophilic dermatophytes, with zoophilic species often leading to severe inflammatory forms, such as kerion Celsi. Kerion Celsi presents as painful nodules and abscesses on the scalp, often accompanied by secondary bacterial infections. Diagnosis is based on mycological examination. Treatment includes systemic antifungals, such as terbinafine or itraconazole, and topical therapy, with an emphasis on accurate diagnosis and timely treatment to prevent complications like scarring alopecia. Prevention involves hygiene measures and minimizing contact with infected animals. The case of an eight-year-old boy illustrates the course of the infection and the importance of a comprehensive treatment approach.

Keywords: tinea capitis, kerion Celsi, dermatophytic infection, Trichophyton benhamiea, antifungal treatment.

Accepted: November 6, 2024; Published: November 22, 2024  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Finsterle J, Gregorová K, Gkalpakiotis S. Suppurating lesion on the scalp. Dermatol. praxi. 2024;18(4):209-212. doi: 10.36290/der.2024.042.
Download citation
PDF will be unlocked 22.11.2025

References

  1. Andrews MD, Burns M. Common tinea infections in children. Am Fam Physician. 2008 May 15;77(10):1415-20. PMID: 18533375.
  2. Hubka V, Čmoková A, Skořepová M, et al. Současný vývoj v taxonomii dermatofytů a doporučení pro pojmenovávání klinicky významných druhů. Čes-slov Derm. 2014;89(4):151-165.
  3. Wertzová V, Bartoňová J, Voxová B. Mykotická infekce kůže způsobená Arthroderma benhamiae (Trichophyton sp.). Čes-slov Derm. 2018;93(2):74-77.
  4. Skořepová M. Tinea Capitis. Čes-slov Derm. 2008;83(6):293-297.
  5. Friedlander SF, Aly R., Krafchik B, et al. Terbinafine in the treatment of Trichophyton tinea capitis: a randomized, double-blind, parallel-group, duration-finding study. Pediatrics. 2002; 109:602-607. Go to original source... Go to PubMed...
  6. Pereira Forjaz D, Arenberger P, Arenbergerová M, et al. Kerion Celsi u dítěte - možnosti diagnostiky a léčby. Čes-slov Derm. 2019;94(1):24-28.
  7. Ang CC, Tay YK. Inflammatory tinea capitis: non-healing plaque on the occiput of a 4-year-old child. Ann. Acad. Med. Singapore. 2010;39(5):412-414. Go to original source...
  8. Fuller LC., Barton RC, Mohd Mustapa, MF, et al. British Association of Dermatologists' guidelines for the management of tinea capitis 2014. British J. Dermatol. 2014;171:454-463. Go to original source... Go to PubMed...
  9. Goldstein AO, Goldstein BG. Dermatophyte (tinea) infections. In: UpToDate, Basow, DS (Ed). UpToDate, Waltham: MA; 2013.
  10. Arenas R., Toussaint S, Isa-Isa R. Kerion and dermatophytic granuloma. Mycological and histo-pathological findings in 19 children with inflammatory tinea capitis of the scalp. Int. J. Dermatol. 2006;45(3):215-219. Go to original source... Go to PubMed...
  11. Leung AKC, Hon, KL, Leong KF, et al. Tinea Capitis: An Updated Review. Recent Pat Inflamm Allergy Drug Discov. 2020;14(1):58-68. doi: 10.2174/1872213X14666200106145624. Go to original source... Go to PubMed...
  12. Borman AM., Campbell CK, Fraser M, et al. Analysis of the dermatophyte species isolated in the British Isles between 1980 and 2005 and review of worldwide dermatophyte trends over the last three decades. Med. Mycol. 2007;45:131-141. Go to original source... Go to PubMed...
  13. Vargas-Navia N, Ayala Monroy GA, Rúa CF, et al. Tiña Capitis en niños [Tinea capitis in children]. Rev Chil Pediatr. 2020;91(5):773-783. Spanish. doi: 10.32641/rchped.vi91i5.1345. Go to original source... Go to PubMed...




Dermatology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.